Delivery Order SPE2DB20D3103-SPE2DB24FL9A4
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,233.85, is for the delivery of Lidocaine HCL 1% Vial 10ML medical supplies. The contract is structured as a Firm Fixed Price Delivery Order and has an ultimate completion date of January 29, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This is a $1,366.67 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine HCL 1% Vial 50ML, a pharmaceutical product, with a period of performance through June 6, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565177080 - Lidocaine HCL 1% Vial 10ML, a pharmaceutical product, with a ceiling value of $1,679.72 and a completion date of July 18, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,731.76 firm-fixed-price delivery order is for the supply of 4560703404 - Lidocaine HCL 1% Vial 2ML, with a period of performance through April 26, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order (SPE2DB23FP5Q4) valued at $1,628.10 for the supply of Lidocaine HCL 2% in 5 mL vials. The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of August 30, 2023 and is a firm fixed price agreement. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
- This federal contract award, valued at $6,214.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,561,611,525 units of Lidocaine HCL 2% Luer-Jet 5ML, a medical product used in various healthcare applications. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,611.60, is for the delivery of 4567117520 - Lidocaine 2% Viscous 15 ML Cup UD 15ML, a pharmaceutical product, to support military healthcare programs. The order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- This firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical on November 30, 2022. The $2,162.40 award is for the supply of 4559223224 - Lidocaine HCL 1% vials, 10mL. This order is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. No...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lidocaine 2% viscous solution in 100ml quantities. The $2,178.33 firm fixed price Delivery Order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of February 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $1,326.40, is for the supply of 4,566,696,903 units of Lidocaine 1% 20ml in packs of 25. This contract is a firm-fixed-price delivery order that does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FL9A4Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,917.62, is for the delivery of Lidocaine HCl 1% Vial 10mL to support military healthcare programs. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military. The contract does not have a set-aside designation, indicating open competition. By leveraging this contract vehicle, the DLA can efficiently procure essential medical commodities to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 12/13/23 |